Liuzhou Chemical Industry Co Ltd

Liuzhou Chemical Industry Co Ltd operates with a current ratio of 8.69, indicating strong short-term liquidity, but reports negative free cash flow of -18.67 million CNY and negative operating income of -29.83 million CNY, signaling operational cash flow challenges. The company's debt-to-equity ratio of 0.06 suggests a conservative capital structure, with long-term debt of 31.55 million CNY against total equity of 526.44 million CNY. The company's return on equity of -4.88% and return on assets of -4.37% fall significantly below the typical performance metrics for the Commodity Chemicals industry, which usually expects positive returns in stable market conditions. This underperformance is exacerbated by a net loss of 25.71 million CNY despite revenue of 137.41 million CNY, indicating margin compression and cost overruns. The company's revenue is concentrated in the domestic Chinese market, with no disclosed international operations or segment breakdowns. This geographic concentration increases exposure to local economic and regulatory shifts, particularly in the environmental and industrial sectors where hydrogen peroxide is a key input. Recent financial trends show declining profitability, with operating income turning negative and free cash flow becoming negative. The company's capital expenditures of -4.53 million CNY suggest ongoing investment in production capacity, but this has not translated into improved margins or returns. Analysts have noted a last actual EPS of 0.05 CNY, which is below the break-even threshold for meaningful shareholder returns. The risk assessment highlights medium liquidity risk due to negative net cash after subtracting total debt, and low dilution risk based on current share structure. However, the company's negative operating income and free cash flow raise concerns about its ability to service debt and fund operations without external financing. Recent filings and transcripts have not disclosed material events or strategic shifts, but the company's financial performance suggests a need for operational restructuring or cost optimization to improve margins and returns. The absence of disclosed international operations or diversification strategies limits visibility into potential growth avenues.